Essentials Biotech Co, Ltd. – FDA 483, Nov 22, 2019
Essentials Biotech Co, Limited, a pharmaceutical OTC drug manufacturer in Suzhou, China, was cited for significant deficiencies during an FDA inspection. Observations included a lack of written production and process controls, inadequate stability studies for drug product expiration dates, failure of the quality control unit to follow change control procedures, and insufficient written procedures and validation for equipment cleaning and maintenance. These issues indicate a broad lack of adherence to cGMP requirements.
ID · 24842a5a-fe19-4af2-ab9a-e318d0574a04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.